Possible roles of CXCL13/CXCR5 axis in the development of bullous pemphigoid.
CXCL13
CXCR5
LL37
bullous pemphigoid
follicular helper T cells
Journal
The Journal of dermatology
ISSN: 1346-8138
Titre abrégé: J Dermatol
Pays: England
ID NLM: 7600545
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
10
06
2020
accepted:
04
11
2020
pubmed:
3
12
2020
medline:
15
5
2021
entrez:
2
12
2020
Statut:
ppublish
Résumé
CXCL13 recruits CXCR5
Identifiants
pubmed: 33264451
doi: 10.1111/1346-8138.15713
doi:
Substances chimiques
Antibodies
0
Autoantigens
0
CXCL13 protein, human
0
CXCR5 protein, human
0
Chemokine CXCL13
0
Receptors, CXCR5
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
353-359Subventions
Organisme : Japan Agency for Medical Research and Development
ID : 18lm0203062h0001
Informations de copyright
© 2020 Japanese Dermatological Association.
Références
Harrington LE, Hatton RD, Mangan PR et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-1132.
Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007; 8: 345-350.
Peters A, Pitcher LA, Sullivan JM et al. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 2011; 35: 986-996.
Le Jan S, Muller C, Plee J et al. IL-23/IL-17 axis activates IL-1β-associated inflammasome in macrophages and generates an auto-inflammatory response in a subgroup of patients with bullous pemphigoid. Front Immunol 2019; 10: 1972.
Sugaya M. The role of Th17-related cytokines in atopic dermatitis. Int J Mol Sci 2020; 21: 1314.
von Stebut E, Boehncke WH, Ghoreschi K et al. IL-17A in psoriasis and beyond: cardiovascular and metabolic implications. Front Immunol 2020; 10: 3096.
Tojo G, Fujimura T, Kawano M et al. Comparison of IL-17 producing cells in different clinical types of alopecia areata. Dermatology 2013; 227: 77-82.
Moser B. CXCR5, the defining marker for follicular B helper T (TFH) cells. Front Immunol 2015; 6: 296.
Jones GW, Jones SA. Ectopic lymphoid follicles: inducible centres for generating antigen-specific immune responses within tissues. Immunology 2016; 147: 141-151.
Fujimura T, Okabe T, Tanita K et al. A novel technique to diagnose non-melanoma skin cancer by thermal conductivity measurements: correlations with cancer stromal factors. Exp Dermatol 2019; 28: 1029-1035.
Fujimura T, Kambayashi Y, Furudate S et al. Receptor activator of NF-κB ligand promotes the production of CCL17 from RANK+ M2 macrophages. J Invest Dermatol 2015; 135: 2884-2887.
Riani M, Muller C, Bour C et al. Blister fluid induces MMP-9-associated M2-Type macrophages in bullous pemphigoid. Front Immunol 2019; 10: 1858.
Karin N, Wildbaum G, Thelen M. Biased signaling pathways via CXCR3 control the development and function of CD4+ T cell subsets. J Leukoc Biol 2016; 99: 857-862.
Tanita K, Fujimura T, Sato Y et al. Minocycline decreases Th2 chemokines from M2 macrophages: Possible mechanisms for the suppression of bullous pemphigoid by traditional bullous disease drugs. Exp Dermatol 2018; 27: 1268-1272.
Lyu C, Fujimura T, Amagai R et al. Increased expression of dermal LL37 may trigger the lymph duct migration of CCR7+ regulatory T cells in extramammary Paget’s disease. J Dermatol Sci 2020; 99(1): 65-68.
Furudate S, Fujimura T, Kambayashi Y et al. Comparison of CD163+ CD206+ M2 macrophages in the lesional skin of bullous pemphigoid and pemphigus vulgaris: the possible pathogenesis of bullous pemphigoid. Dermatology 2014; 229: 369-378.
Fang H, Li Q, Wang G. The role of T cells in pemphigus vulgaris and bullous pemphigoid. Autoimmun Rev 2020; 19(11): 102661.
Kowalski EH, Kneibner D, Kridin K, Amber KT. Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid. Autoimmun Rev 2019; 18: 526-534.
Chakievska L, Holtsche MM, Künstner A et al. IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid. J Autoimmun 2019; 96: 104-112.
Chamilos G, Gregori ZJ, Meller S et al. Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37. Blood 2012; 210: 3699-3707.
Fuentes-Duculan J, Bonifacio KM, Hawkes JE et al. Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes. Exp Dermatol 2017; 26: 1075-1082.
Giusti D, Bini E, Terryn C et al. NET formation in bullous pemphigoid patients with relapse is modulated by IL-17 and IL-23 interplay. Front Immunol 2019; 10: 701.
Herster F, Bittner Z, Archer NK et al. Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasis. Nat Commun 2020; 11: 105.
Lee KH, Kronbichler A, Park DD et al. Neutrophil extracellular traps (NETs) in autoimmune diseases: a comprehensive review. Autoimmun Rev 2017; 16: 1160-1173.
Kamata M, Asano Y, Shida R et al. Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid. J Dermatol 2019; 46: e216-e217.